This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n9http://linked.opendata.cz/resource/drugbank/drug/DB04740/identifier/pubchem-compound/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04740/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04740/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04740/identifier/pdb/

Statements

Subject Item
n2:DB04740
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB04740 n13:DB04740
dcterms:title
MOXALACTAM (HYDROLYZED)
adms:identifier
n9:5288864 n10:46507244 n11:DB04740 n12:MX1
n5:IUPAC-Name
n6:271B4EDA-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4EE0-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4EDF-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4EDC-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4EDD-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4EDE-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4ED8-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4ED6-363D-11E5-9242-09173F13E4C5 n6:271B4ED9-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4ED7-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4EE6-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4EE7-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4EE1-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4EE2-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4EE4-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4EE3-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4EE5-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4EEC-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4EEE-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4EEF-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4EEB-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4EEA-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4EED-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4EDB-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4EE8-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4EE9-363D-11E5-9242-09173F13E4C5